3 Companies Rising on News for Thursday 16th March 2023
Episode 1268, Mar 16, 2023, 10:30 AM
3 Companies Rising on News for Thursday 16th March 2023
1. Kooth #KOO - Significant US contract in California
Contract sees Kooth selected as the primary vendor partner to deliver its digital mental health platform to all 13-25 year olds in California
Kooth, a global leader in youth digital mental well-being, is delighted to announce that it has been selected as the primary vendor partner by the California Department of Health Care Services to deliver its digital mental well-being platform for children and young adults (ages 13-25) as part of California Governor Gavin Newsom's $4.7 billion investment in youth behavioral health, the Master Plan for Kids' Mental Health, and the Children and Youth Behavioral Health Initiative.
The Contract is subject to definitive legal documentation over the coming weeks, following which a further announcement will be made.
2. OKYO Pharma #OKYO - Listing of Trial on the ClinicalTrials.gov Website
OKYO Pharma announced that its planned trial evaluating the efficacy and safety of OK-101 in subjects with DED has been posted on the ClinicalTrials.gov public website (ClinicalTrials.gov Identifier: NCT05759208).
OKYO is presently in the process of activating those clinical sites planned for the trial, and preparing the clinical trial drug product OK-101 for shipment to those sites involved in the double-blind, placebo-controlled trial, along with other activities needed for initiating the trial.
OKYO is now anticipating the first-patient first-visit initiation of the trial in early Q2 2023 and still looking to release top-line data from this trial in Q4 2023.
3. OneSavings Bank #OSB - Preliminary results for the year ended 31 December 2022
Underlying profit before tax increased by 13% to a record £591.1m (2021: £522.2m) and statutory profit before tax increased by 14% to £531.5m (2021: £464.6m) primarily due to growth in the loan book, an improved net interest margin and net fair value gains on financial instruments.
Underlying and statutory net loan book increased by 12% to £23.5bn and £23.6bn, respectively (2021: £20.9bn and £21.1bn) supported by organic originations of £5.8bn, up 29% from £4.5bn in 2021
See more risers & fallers here
1. Kooth #KOO - Significant US contract in California
Contract sees Kooth selected as the primary vendor partner to deliver its digital mental health platform to all 13-25 year olds in California
Kooth, a global leader in youth digital mental well-being, is delighted to announce that it has been selected as the primary vendor partner by the California Department of Health Care Services to deliver its digital mental well-being platform for children and young adults (ages 13-25) as part of California Governor Gavin Newsom's $4.7 billion investment in youth behavioral health, the Master Plan for Kids' Mental Health, and the Children and Youth Behavioral Health Initiative.
The Contract is subject to definitive legal documentation over the coming weeks, following which a further announcement will be made.
2. OKYO Pharma #OKYO - Listing of Trial on the ClinicalTrials.gov Website
OKYO Pharma announced that its planned trial evaluating the efficacy and safety of OK-101 in subjects with DED has been posted on the ClinicalTrials.gov public website (ClinicalTrials.gov Identifier: NCT05759208).
OKYO is presently in the process of activating those clinical sites planned for the trial, and preparing the clinical trial drug product OK-101 for shipment to those sites involved in the double-blind, placebo-controlled trial, along with other activities needed for initiating the trial.
OKYO is now anticipating the first-patient first-visit initiation of the trial in early Q2 2023 and still looking to release top-line data from this trial in Q4 2023.
3. OneSavings Bank #OSB - Preliminary results for the year ended 31 December 2022
Underlying profit before tax increased by 13% to a record £591.1m (2021: £522.2m) and statutory profit before tax increased by 14% to £531.5m (2021: £464.6m) primarily due to growth in the loan book, an improved net interest margin and net fair value gains on financial instruments.
Underlying and statutory net loan book increased by 12% to £23.5bn and £23.6bn, respectively (2021: £20.9bn and £21.1bn) supported by organic originations of £5.8bn, up 29% from £4.5bn in 2021
See more risers & fallers here